Tesofensine
Also known as: NS-2330, Triple Monoamine Reuptake Inhibitor, Oral Metabolic Compound
Studied in published research — not a medical recommendation. Primary protocol (TIPO-1 Clinical Trial Oral Protocol): 250 mcg – 500 mcg (0.25 mg – 0.5 mg), Once daily in the morning (long ~8–9 day half-life).
Once daily in the morning (long ~8–9 day half-life)
Research-reported range; the linked study used a different dose or units. Must be taken early in the morning due to its ~9-day plasma half-life
Oral capsule/tablet
Human clinical trials or FDA-approved formulation exists
No verified human half-life on file for this compound
A vial is powder until you add bacteriostatic water. Change the vial size or water volume below to see the exact unit mark on your syringe.
All U-100: 100 units = 1 mL. 20 doses in the vial at the low end (10 doses at the high end).
Save Tesofensine to your personal protocol list to log your custom dosage, syringe units, ON/OFF cycle dates, and lab notes across devices.
Tesofensine supplier & $/mg comparison.
At a Glance · 2026 FDA / 503A / WADA / Evidence Profile
Bottom Line Up Front
Tesofensine (NS-2330) is an oral phenyltropane small molecule (not a peptide) that inhibits the presynaptic reuptake of dopamine, norepinephrine, and serotonin. Phase 2 human trials (TIPO-1, Lancet) demonstrated ~10.6% weight loss in 24 weeks at 0.5 mg/day via central appetite suppression and increased resting thermogenesis.
Published preclinical & translational clinical protocols
Large multi-year outcomes in healthy non-clinical cohorts
None
3 (0 human)
EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE. Tesofensine is not FDA approved for human use (unless specified above). This information does not constitute medical advice.
Overview
Tesofensine is a centrally acting triple monoamine neurotransmitter reuptake inhibitor (SNDRI) originally investigated for neurodegenerative conditions before researchers observed consistent, dose-dependent weight loss. In the landmark Phase 2 TIPO-1 randomized trial published in The Lancet, 0.5 mg once daily produced nearly double the weight loss of previously approved oral anti-obesity agents while preserving mood and motivation during caloric restriction.
Mechanisms of Action
- Inhibits presynaptic reuptake of norepinephrine, dopamine, and serotonin in hypothalamic satiety centers
- Stimulates alpha-1 adrenoceptor and D1 dopamine receptor pathways to reduce hunger and food cravings
- Increases nocturnal fat oxidation and 24-hour energy expenditure (~6% increase in human calorimeter studies)
Research Protocols
Summaries of published research. For educational purposes only.
Metabolic, Hepatic & Incretin Safety Biomarker Panel (Tesofensine)
Quantify visceral fat mobilization, insulin resistance reversal, hepatic steatosis (MASH) clearance, and pancreatic/renal safety during metabolic protocols.
HbA1c & Fasting Insulin (HOMA-IR)
Day 0 + Wk 6–8Why track at baseline: Measures baseline hyperinsulinemia and 90-day glycemic load prior to incretin or lipolytic initiation.
Week 6–8 check: Track rapid drop in Fasting Insulin (often 30%–50% reduction by Week 6–8) and normalizing HbA1c.
ALT, AST & GGT Liver Enzymes
Day 0 + Wk 6–8Why track at baseline: Dual/triple agonists (Retatrutide, Mazdutide, Pemvidutide) mobilize 65%–80% of intrahepatic triglycerides.
Week 6–8 check: Confirm progressive reduction in ALT/AST (<25 U/L) as hepatic steatosis clears.
ApoB, Triglycerides & Advanced Lipid Panel
Day 0 + Wk 6–8Why track at baseline: Quantifies atherogenic particle burden and VLDL triglyceride export before weight loss.
Week 6–8 check: Expect 20%–40% triglyceride drop and significant ApoB improvement alongside visceral fat loss.
Serum Lipase, Amylase & eGFR / Cystatin C
Day 0 + Wk 6–8Why track at baseline: Essential safety screen for subclinical pancreatic inflammation and hydration/renal filtration.
Week 6–8 check: Ensure Lipase stays within reference range and eGFR remains stable with adequate electrolyte hydration.
Community Outcomes
Community Data Coming Soon
Aggregate community outcomes will be displayed here once we have more reports. Be one of the first to share your experience!
Outcomes are self-reported and unverified. They represent individual experiences and may not reflect typical results.
Important Warnings
- •Do NOT combine with SSRIs, SNRIs, MAOIs, or high-dose stimulants (serotonin/sympathomimetic interaction risk)
- •Monitor resting heart rate and blood pressure (1.0 mg doses in trials elevated HR by ~7–8 bpm; 0.25–0.5 mg is preferred)
Where to get Tesofensine, baseline labs & clinician oversight.
Ascension Peptides (US Vials)
MZ Biolabs & SafeCert COA-verified US domestic single vials with 50% off auto-applied for new customers.
SwissChems & Limitless Biotech
Same-day US domestic lyophilized vials, oral capsules, and endotoxin-screened nasal sprays (15% off Limitless w/ code PEPTIDEPROTOCOLS).
Superpower Labs & 503A Telehealth
Bloodwork, not a vial store. Get a baseline panel (100+ Quest biomarkers: metabolic, lipids, hormones, inflammation, kidney/liver) before you start a peptide protocol, then retest mid-cycle to see what actually changed.
Where to buy Tesofensine: best verified price
Prices checked Nov 11, 2026 · sorted by $/mg · RUO
- 1. Elite Research USA — $9.00/mg (10mg vial, $90.00)
Where is the cheapest place to buy Tesofensine?
As of Nov 11, 2026, the lowest verified US domestic single-vial price we found is Elite Research USA at $9.00/mg (10mg vial, $90.00). We compared 1 US supplier with live, checked prices.
How much does Tesofensine cost per mg?
Verified US domestic prices currently range from $9.00/mg to $9.00/mg depending on supplier and vial size. Larger vials usually lower the $/mg.
How are these prices verified?
Each price is read from the supplier's own product page or store data and divided by the vial's mg. Suppliers we could not verify are left out rather than estimated. Tables sort strictly by $/mg, never by partner status. Prices are re-checked weekly on our price index.
Is Tesofensine approved for human use?
Products from these suppliers are sold for laboratory research use only (RUO). This page is an educational price reference, not medical advice.
All compounds $/mgWeekly $/mg price indexReconstitution calculatorFree cheat sheet
Peptide Reconstitution & U-100 Syringe Cheat Sheet
Printable U-100 insulin syringe draw chart for 5mg–50mg vials, plus our weekly $/mg price-drop brief.
Related Peptides
More metabolic peptides
Semaglutide
Semaglutide is a GLP-1 receptor agonist that mimics the horm...
Tirzepatide
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It rep...
Retatrutide
Retatrutide is a triple hormone receptor agonist developed b...
Liraglutide
Liraglutide is an FDA-approved GLP-1 receptor agonist used f...
AOD-9604 (hGH Frag 176-191)
AOD-9604 is a modified fragment of human growth hormone (hGH...
Vendor vs vendor: price per mg
Head-to-head $/mg on shared compounds. Prices verified Nov 11, 2026.
- Ascension vs SwissChems (3 shared compounds)
- Elite vs SwissChems (3 shared compounds)
- Elite vs Ascension (26 shared compounds)
- Protide vs SwissChems (3 shared compounds)
- Protide vs Ascension (6 shared compounds)
- Ameano vs SwissChems (3 shared compounds)
- Ameano vs Ascension (4 shared compounds)
- Swift vs Ascension (23 shared compounds)
- BioLongevity vs Ascension (16 shared compounds)
- Peptyes vs SwissChems (3 shared compounds)
- Peptyes vs Elite (20 shared compounds)
- Peptyes vs Swift (17 shared compounds)
- Peptyes vs Pure (17 shared compounds)
- Peptyes vs Ascension (20 shared compounds)
Compound vs compound: BPC-157 vs TB-500 · Tirzepatide vs Semaglutide · Retatrutide vs Tirzepatide · Wolverine Blend vs GLOW Blend · Semax vs Selank · KLOW Blend vs GLOW Blend · MOTS-c vs SS-31 · Sermorelin vs Ipamorelin · Retatrutide vs Semaglutide · Tesamorelin vs Sermorelin · All compounds $/mg →
Common questions
How many peptides are in the database?
100 compound pages, each with dosing references, reconstitution math and price per mg where a verified vendor price exists.
Where can I compare peptide prices?
Each compound page shows verified $/mg by vendor; the vendor-vs-vendor pages above compare two vendors across their shared compounds.